Onkure Therapeutics, Inc. · NASDAQ:OKUR
Cantor Fitzgerald Securities reported a 5.20% stake in Onkure Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 14, 2025
Cantor Fitzgerald Securities reported a 5.20% stake in Onkure Therapeutics, Inc., 669,539 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 669,539
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cantor Fitzgerald Securities | 5.20% | 669,539 |
| Cantor Fitzgerald & Co. | 5.20% | 669,539 |
| Cantor Fitzgerald, L.P. | 5.20% | 669,539 |
| CF Group Management, Inc. | 5.20% | 669,539 |
Source
Related
- Onkure Therapeutics, Inc.
- Cantor Fitzgerald & Co.
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026